Janux Therapeutics (JANX)
(Real Time Quote from BATS)
$36.24 USD
+0.95 (2.69%)
Updated Aug 8, 2024 09:56 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 37% (93 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.25 | 1.35 | 9.99 |
Current Quarter Estimate | -0.32 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -0.25 | 0.12 | 54.84 |
Next Quarter Estimate | -0.34 | 7.81 | 63.00 |
Next Year Estimate | -1.63 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -1.52 | 16.40 | 15.67 |
Next Year | -21.64 | 9.60 | 11.34 |
Last 5 Years | NA | 0.70 | 8.10 |
Next 5 Years | 4.80 | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 2.79 | 2.03 |
Price/Cash Flow (MRFY) | NA | 16.15 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -291.17% | -22.37% |
Return on Equity (TTM) | -9.79% | -31.10% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.